Sovran Advisors, LLC

Position in GALT — Galectin Therapeutics Inc

CIK 2051471 SAN DIEGO, CA

Position in GALT

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$1,197,106

+$477,761 QoQ

Shares Held

257,997

+0.1% QoQ

Ownership

0.256%

of shares outstanding

% of Portfolio

0.25%

of 13F equity value

Holder Rank

#14

of 98 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Sovran Advisors, LLC holds $9,234,344 across 5 Biotechnology names. GALT ranks #2 (13.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	84,984	$6,738,381
2	GALT	Galectin Therapeutics Inc This page	257,997	$1,197,106
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,479	$734,663
4	REGN	Regeneron Pharmaceuticals, Inc.	516	$321,746
5	ASND	Ascendis Pharma A/S	909	$242,448

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,197,106	257,997	+0.1%	Shares	Sole	2026-07-30
2026-03-31	$719,345	257,830	+14.1%	Shares	Sole	2026-05-01
2025-12-31	$939,635	225,874	+43.5%	Shares	Sole	2026-01-20
2025-09-30	$667,397	157,405	-16.7%	Shares	Sole	2025-10-31
2025-06-30	$398,730	188,972	-5.4%	Shares	Sole	2025-07-10
2025-03-31	$243,792	199,830	+7.4%	Shares	Sole	2025-04-25
2024-12-31	$239,958	186,014	—	Shares	Sole	2025-01-29
No filing history on record for this holder in this stock.